Researchers have been studying the structural basis of translation inhibition by a novel antibiotic. The focus of the study appears to be on a specific class of antibiotics, with some reports mentioning cadazolid, a quinoxolidinone antibiotic, while others refer to oxazolidinone antibiotics. The study aims to understand how these antibiotics inhibit translation, although the specific type of antibiotic being studied is not consistently reported.